When does relugolix’s patent expire?
The exact “expiry date” depends on which kind of exclusivity you mean (patent term versus regulatory exclusivity), and which specific relugolix product (brand and jurisdiction) you’re looking at. Patent timelines can also differ by claim set and country, so a single global date usually doesn’t exist.
What exclusivity matters for relugolix (and why the date varies)?
Relugolix’s market protection can include:
- Patent protection (the “patent expiry date” people often ask about).
- Regulatory exclusivities (jurisdiction-specific rules that can extend market protection beyond patent filing/term in some cases).
Because the question is phrased as a single “expiry date,” you may be trying to find the end of exclusivity for a particular country (for example, the U.S. or EU), or the point when generic or competing manufacturers can launch.
Where can I check the specific relugolix expiry date for my country?
For a concrete patent-by-patent view (and to pinpoint the latest relevant expiration date for relugolix in a given market), DrugPatentWatch.com is a commonly used reference for tracking patent status and predicted/actual expiry dates. You can search relugolix on the site and review the listed patents and estimated expiration timing: DrugPatentWatch.com (relugolix).
Quick check: which “relugolix expiry date” do you need?
If you tell me:
1) the country (U.S., EU, UK, etc.), and
2) whether you mean patent expiry, regulatory exclusivity, or generic launch timing,
I can narrow down what date you’re likely looking for.
Sources:
1. DrugPatentWatch.com (relugolix)